Ads
related to: Psoriatic Arthritis Medicine- PsO & Psoriatic Arthritis
Learn More About The Connection
& View Patient Resources.
- Register For Savings
Sign Up For Information, Updates,
& A $0 Co-Pay Savings Offer.
- Clinical Trial Results
Get The Facts On How Treatment
Performed In Clinical Trials Here.
- The PsO & PsA Connection
See The Signs & Symptoms Of PsA
To Look Out For If You Have PsO.
- Plaque Psoriasis In Kids
See A Treatment Option
For Children 6 Years & Older.
- Discussion Guide
Questions To Ask Before Seeing Your
Doctor To Talk About Treatment.
- PsO & Psoriatic Arthritis
Search results
Johnson & Johnson (JNJ) Scheduled to Post Quarterly Earnings on Tuesday
ETF DAILY NEWS· 6 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, April 16th. Analysts expect Johnson & Johnson to ...
Johnson & Johnson (NYSE:JNJ) Releases FY 2024 Earnings Guidance
ETF DAILY NEWS· 17 hours agoJohnson & Johnson (NYSE:JNJ – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company issued revenue guidance of $88.0 billion-$88.4 billion, compared to the consensus ...
Johnson & Johnson (NYSE:JNJ) Price Target Lowered to $175.00 at Royal Bank of Canada
ETF DAILY NEWS· 2 days agoJohnson & Johnson (NYSE:JNJ – Free Report) had its target price cut by Royal Bank of Canada from $181.00 to $175.00 in a research note released on Wednesday morning, Benzinga reports. StockNews.com ...
Johnson & Johnson (NYSE:JNJ) Stock Holdings Lowered by Schmidt P J Investment Management Inc.
ETF DAILY NEWS· 2 days agoSchmidt P J Investment Management Inc. decreased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 21.2% during the 4th quarter, according to the company in its most recent disclosure ...
Johnson & Johnson (NYSE:JNJ) Issues FY24 Earnings Guidance
ETF DAILY NEWS· 17 hours agoJohnson & Johnson (NYSE:JNJ – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $10.57-10.72 for the period, compared to the consensus EPS ...
Wealthspan Partners LLC Raises Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoWealthspan Partners LLC boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 6.0% during the fourth quarter, according to its most recent disclosure with the Securities and ...
YHB Investment Advisors Inc. Trims Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 19 hours agoYHB Investment Advisors Inc. reduced its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Clarus Group Inc. Reduces Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoClarus Group Inc. trimmed its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 39.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & ...
Ingalls & Snyder LLC Sells 4,104 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 19 hours agoIngalls & Snyder LLC reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Acelyrin, Inc. (NASDAQ:SLRN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 6 days agoShares of Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven research firms that are covering the stock, MarketBeat ...
Ads
related to: Psoriatic Arthritis Medicine